Coya Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Coya Therapeutics's estimated annual revenue is currently $1M per year.
- Coya Therapeutics's estimated revenue per employee is $77,500
- Coya Therapeutics's total funding is $10M.
Employee Data
- Coya Therapeutics has 13 Employees.
- Coya Therapeutics grew their employee count by 18% last year.
Coya Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Development Officer | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | SVP Regulatory Affairs | Reveal Email/Phone |
4 | VP Regulatory Affairs | Reveal Email/Phone |
5 | VP, Operations and Patient Advocacy | Reveal Email/Phone |
6 | SVP Regulatory Affairs | Reveal Email/Phone |
7 | President and Chief Medical Officer | Reveal Email/Phone |
8 | Chief Executive officer and Chairman | Reveal Email/Phone |
9 | CFO and Chief Operating Officer | Reveal Email/Phone |
10 | President & Chief Medical Officer | Reveal Email/Phone |
Coya Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Coya Therapeutics?
The company's proprietary CTreg™ (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf' approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAI™ (Exosomes Against Inflammation) platforms , Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson's, Alzheimer's, FTD and autoimmune diseases.
keywords:N/A
$10M
Total Funding
13
Number of Employees
$1M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Coya Therapeutics News
Coya Therapeutics to Participate in B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference. ? Fireside Chat with B. Riley Research...
About Coya Therapeutics, Inc. Headquartered in Houston, TX, Coya Therapeutics is a clinical-stage biotechnology company developing first-in-...
A Houston company has emerged from stealth mode to announce a merger and a round of financing. Coya Therapeutics, a clinical-stage biotech startup that focuses on creating therapeutics for neurodegenerative and autoimmune diseases, announced that it has completed a merger with Nicoya Health Inc ...
-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and neurologist- HOUSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya), a clin ...
Other Companies in Houston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 13 | 0% | N/A |
#2 | $1.9M | 13 | N/A | N/A |
#3 | $1.1M | 13 | N/A | N/A |
#4 | $1.7M | 13 | N/A | N/A |
#5 | $3.1M | 13 | -35% | N/A |